Regorafenib monohydrate is a multi-kinase inhibitor used as an active pharmaceutical ingredient. It is an oral compound that targets angiogenic, stromal, and oncogenic receptor tyrosine kinases, including dual inhibition of VEGFR2 and TIE2.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1019206-88-2
Regorafenib
active pharmaceutical ingredient
Sorafenib
n.a
Sorafenib tosylate
active pharmaceutical ingredient
Sulfaclozine
veterinary antimicrobial medication
Xanthoanthrafil
pharmaceutical impurity reference standard
Paliperidone-d4 (Major)
active pharmaceutical ingredient
4-amino-2,3,5,6-tetradeuterio-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
deuterated sulfamethoxazole
4-[4-[[[[2-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
Pharmaceutical reference standard intermediate
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;hydrate
ZOPOQLDXFHBOIH-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.O